Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contezolid (Youxitai) oral tablets in pediatric complex skin and soft tissue infections
CTR20230232Phase 2Active
- Sponsor
- MicuRx Pharmaceuticals
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of contezolid in skin and soft tissue infections (SSTIs), sponsored by MicuRx Pharmaceuticals. Started Jan 2023; status: active.
02
Drugs
contezolid
03
Conditions
skin and soft tissue infections (SSTIs)
Beyond the preview
Go deeper on CTR20230232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230232.